Status:
RECRUITING
Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Early Gastric Cancer
Colon Neoplasia
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Endoscopic submucosal dissection (ESD) is a technique that allows curative treatment of early gastrointestinal neoplasia with organ preservation. However, it is a technically demanding procedure. Tiss...
Detailed Description
Gastrointestinal (GI) cancers accounted for 39.5 million new cases worldwide in 2020, representing 14.7% of the total new cases of cancer. These cancers also led to 18.8 million deaths, constituting 1...
Eligibility Criteria
Inclusion
- Patient with superficial gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD).
Exclusion
- Patient who refused to participate
- Other cases deemed by the examining physician as unsuitable for safe treatment
- The robotic magnetic countertraction system consist of a strong permanent magnet which always have a strong magnetic field in its surrounding. Therefore, we follow the MRI precautions for the strict safety measurement:
- Patient who had a cardiac pacemaker.
- Patient who had any metallic implant or device, such as drug pump, stent, etc.
- Patient who has or had any metal fragments in eye or any other part of body, or had ever worked with metal.
Key Trial Info
Start Date :
May 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06962293
Start Date
May 9 2025
End Date
June 30 2026
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong
Hong Kong, Hong Kong